EchoNous
Focus: EchoNous develops ultrasound diagnostic devices and algorithms, with a focus on bladder scanning and cardiac applications in cardiovascular and nephrology markets. The company operates as a specialized medical device innovator rather than a traditional pharmaceutical manufacturer.
Profile data last refreshed 17h ago · AI intelligence enriched 2w ago
Open Jobs
0
About EchoNous
AI assessmentNot HiringNo open roles listed right now. Follow EchoNous to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
6 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Early Assessment and Initiation of GuideLine-Directed Evidence-Based Management-HF
Heart FailureKosmos Anatomical Object Labeling and View Identification Algorithms
Cardiac DisorderClinical Trials (1)
Help build intelligence for EchoNous
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.